ArticleCureus2025
Comparative Analysis of Tumor Characteristics, Treatment Response, and Oncological Outcomes in Early-Onset Versus Late-Onset Colorectal Cancer: A Retrospective Cohort Study.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Young-onset versus late-onset colorectal cancer: clinicopathological features and survival outcome: a decade-long analysis from a middle Eastern tertiary center.World journal of surgical oncology · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionColorectal cancer is a leading cause of cancer-related mortality worldwide, with distinct clinical features observed between early-onset colorectal cancer (EOCRC, ≤50 years) and late-onset colorectal cancer (LOCRC, >50 years). Recent trends indicate an alarming rise in EOCRC incidence, underscoring the importance of understanding its unique tumor biology and clinical behavior. Therefore, the aim of this study is to compare the tumor characteristics, clinico-pathological features, and oncological outcome between EOCRC and LOCRC. STUDY METHODOLOGY: This retrospective cohort study evaluated 162 patients with histopathologically confirmed colorectal adenocarcinoma who underwent treatment with curative intent at Sindh Institute of Urology and Transplantation, Karachi, Pakistan, between August 2018 and July 2023. Patients were stratified into EOCRC (n=78) and LOCRC (n=84) groups. Clinical data, including demographics, tumor location, histological differentiation, staging, treatment modalities, and recurrence patterns, were extracted from medical records and analyzed using chi-square tests and Kaplan-Meier survival estimates.
resultsEOCRC patients more frequently presented with rectal tumors, poorly differentiated histology, and advanced stage disease at diagnosis. Although pathological staging and resection margins were comparable, the EOCRC group exhibited a significantly higher incidence of distant recurrence and lower rates of complete pathological response to neoadjuvant chemoradiotherapy. At 24 months, both disease-free and overall survival were markedly lower in EOCRC compared to LOCRC patients.
conclusionThe study demonstrates that EOCRC is characterized by aggressive tumor behavior and poorer oncological outcomes. These findings support the need to revise screening strategies, such as lowering the age threshold and incorporating flexible sigmoidoscopy, to enhance early detection and improve patient prognosis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.